Blue-Zone Technologies signs LOI with Cdn. manufacturer
by CM Staff
Both parties are considering entering into a collaboration agreement wherein the parties will explore the collection of WAGs for delivery to Blue-Zone.
TORONTO — Blue-Zone Technologies Ltd., a Canadian cleantech pharmaceutical company that leverages technology to capture and convert waste anesthetic gases (WAGs) from healthcare facilities, announced it has signed a letter of intent with a medical gas equipment manufacturer, distributor and service provider, Class 1 Incorporated. Both parties are considering entering into a collaboration agreement wherein the parties will explore the collection of WAGs for delivery to Blue-Zone.
Under this agreement, Class 1 would supply WAGs collected by its piped, centralized recovery system to Blue-Zone, which Blue-Zone would then convert into a marketable anesthetic product. With Blue-Zone’s patented process, WAGs collected in the containers from hospital operating rooms are desorbed in Blue-Zone’s manufacturing facility. The raw material from desorption is then put through Blue-Zone’s patented distillation process to produce a sustainable, pure, branded generic, inhalation anesthetic that can be used again in operating rooms.
“At Blue-Zone, we want to ensure the safe removal of harmful waste gases from the hospital environment and the surrounding community. We also want to create a sustainable source of anesthetic gases that can help reduce costs and waste within the medical community,” said Kipton Lade, CEO of Blue-Zone Technologies. “The use of anesthetic gases is forecast to grow globally by 4% to 5% per year and our collaboration with Class 1 will enable more waste gas to be collected and converted to fill that need with pure, branded generic anesthetics.”
“Blue-Zone and Class 1 have shared values, including the development of new technology to improve the industry and the implementation of technology to better protect the environment and the planet,” said Michael Sue, President and General Manager of Class 1 Incorporated. “We look forward to developing an agreement that is not only mutually beneficial for both companies, but also beneficial for the environment and the healthcare community at large.”
